March 2023 - Beactica Therapeutics' CEO, Dr Per Källblad, presents the investment opportunity related to the company's transition into a clinical-stage company.
September 2018 - Beactica Therapeutics' CEO, Dr Per Källblad, presents talk entitled "Targeting LSD1 in aggressive brain tumors" during Nordic Life Science Days (NLSDays) in Stockholm (10–12 September 2018).
Stay Updated
Sign up for the Beactica newsletter to receive our latest news and updates